ArticlePloS one2015

Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells.

Luyuan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.